3-Methyl-PCP

{{Short description|Chemical compound}}

{{drugbox

| drug_name = 3'-Me-PCP

| image = 3'-Me-PCP.svg

| image_class = skin-invert-image

| legal_CA = Schedule I

| legal_UK = Class B

| legal_DE = NpSG

| C = 18 | H = 27 | N = 1

| IUPAC_name = 1-[1-(3-methylphenyl)cyclohexyl]piperidine

| CAS_number_Ref = {{cascite|correct|CAS}}

| CAS_number = 2201-30-1

| UNII_Ref = {{fdacite|correct|FDA}}

| UNII = Y9XHS38QLZ

| ChemSpiderID = 531905

| PubChem = 611899

| smiles = CC1=CC(=CC=C1)C2(CCCCC2)N3CCCCC3

| StdInChI = 1S/C18H27N/c1-16-9-8-10-17(15-16)18(11-4-2-5-12-18)19-13-6-3-7-14-19/h8-10,15H,2-7,11-14H2,1H3

| StdInChIKey = BMFKUCGCXMDGBK-UHFFFAOYSA-N

}}

3-Methyl-PCP (3'-Methyl-PCP, meta-Methyl-PCP, 3-Me-PCP) is a recreational designer drug with dissociative effects. It is an arylcyclohexylamine derivative, related to drugs such as 3'-MeO-PCP and 3'-Me-PCPy.{{cite journal | vauthors = Linders J, Furlano DC, Mattson MV, Jacobson AE, Rice KC | title = Synthesis and preliminary biochemical evaluation of novel derivatives of PCP. | journal = Letters in Drug Design & Discovery| date = February 2010 | volume = 7 | issue = 2 | pages = 79–87 | doi = 10.2174/157018010790225813 }}{{cite journal | vauthors = Wallach J, De Paoli G, Adejare A, Brandt SD | title = Preparation and analytical characterization of 1-(1-phenylcyclohexyl)piperidine (PCP) and 1-(1-phenylcyclohexyl)pyrrolidine (PCPy) analogues | journal = Drug Testing and Analysis | volume = 6 | issue = 7–8 | pages = 633–50 | date = 2014 | pmid = 23554350 | doi = 10.1002/dta.1468 }} It was first synthesised in the 1960s,{{cite journal | vauthors = Maddox VH, Godefroi EF, Parcell RF | title = The synthesis of phencyclidine and other 1-arylcyclohexylamines. | journal = Journal of Medicinal Chemistry | volume = 8 | issue = 2| pages = 230–5 | date = March 1965 | pmid = 14332667 | doi = 10.1021/jm00326a019 }} but was only identified on the illicit market in Hungary in September 2020,{{cite web | vauthors = Jankovic M | date = 28 January 2021 | work = Der Koordinator für Psychiatrie, Sucht- und Drogenfragen und der Beauftragte für Sucht- und Drogenfragen der Stadt Wien | url = https://www.aekwien.at/documents/263869/825989/210201_EWS+Information+Jaenner.pdf | title = EU Early Warning System }} and was made illegal in Hungary in April 2021.{{cite web | author = Minister for Human Capacities | url = https://ec.europa.eu/growth/tools-databases/tris/index.cfm/en/search/?trisaction=search.detail&year=2021&num=225&dLang=EN | title = Amendment of Minister for Human Capacities Decree No 55/2014 of 30 December 2014 on substances or groups of compounds classified as new psychoactive substances, 2021/225/HU | publisher = European Commission }}

See also

References

{{reflist}}

{{Hallucinogens}}

{{Glutamate receptor modulators}}

{{Sigma receptor modulators}}

Category:Arylcyclohexylamines

Category:Designer drugs

Category:Dissociative drugs

Category:Substances discovered in the 1960s

{{hallucinogen-stub}}